The increased reliance on decentralized clinical trials creates a greater need for true digital patient engagement. When trial participants better understand trial protocols and associated risks and benefits and have a meaningful consent conversation where their questions and concerns are addressed, that engagement can favorably impact participant conversion, protocol adherence, and retention rates. And 5thPort’s electronic informed consent software is digital, simplifying consent related audit and regulatory compliance.
With hybrid and virtual clinical trials quickly gaining steam, eConsent is fast becoming a critical capability. With functionality specifically designed to manage decentralized or site-based (US and/or international) trials, 5thPort’s patient engagement and eConsent is hands down, the best platform in the market.